The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Prognostic biomarkers in osteoarthritis
Open accessAbstract
PURPOSE OF REVIEW: Identification of patients at risk for incident disease or disease progression in osteoarthritis remains challenging, as radiography is an insensitive reflection of molecular changes that presage cartilage and bone abnormalities. Thus there is a widely appreciated need for biochemical and imaging biomarkers. We describe recent developments with such biomarkers to identify osteoarthritis patients who are at risk for disease progression. RECENT FINDINGS: The biochemical markers currently under evaluation include anabolic, catabolic, and inflammatory molecules representing diverse biological pathways. A few promising cartilage and bone degradation and synthesis biomarkers are in various stages of development, awaiting further validation in larger populations. A number of studies have shown elevated expression levels of inflammatory biomarkers, both locally (synovial fluid) and systemically (serum and plasma). These chemical biomarkers are under evaluation in combination with imaging biomarkers to predict early onset and the burden of disease. SUMMARY: Prognostic biomarkers may be used in clinical knee osteoarthritis to identify subgroups in whom the disease progresses at different rates. This could facilitate our understanding of the pathogenesis and allow us to differentiate phenotypes within a heterogeneous knee osteoarthritis population. Ultimately, such findings may help facilitate the development of disease-modifying osteoarthritis drugs (DMOADs).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stannus, O., Jones, G., Cicuttini, F., Parameswaran, V., Quinn, S., Burgess, J., & Ding, C. (2010) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2010.08.016 · Cited by 510
Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis
Kraus, V. B., Burnett, B., Coindreau, J., Cottrell, S., Eyre, D., Gendreau, M., Gardiner, J., Garnero, P., Hardin, J., Henrotin, Y., et al. (2011) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2010.08.019 · Cited by 328
Cited by
Rahmati, M., Mobasheri, A., & Mozafari, M. (2016) · Bone · doi:10.1016/j.bone.2016.01.019 · Cited by 374
Mechanistic biomarkers for clinical decision making in rheumatic diseases
Robinson, W. H., Lindstrom, T. M., Cheung, R. K., & Sokolove, J. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.14 · Cited by 109
Joseph, G. B., Nevitt, M. C., McCulloch, C. E., Neumann, J., Lynch, J. A., Heilmeier, U., Lane, N. E., & Link, T. M. (2018) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2018.04.019 · Cited by 29
Waluyo, Y., Budu, Bukhari, A., Adnan, E., Darjanti Haryadi, R., Idris, I., Hamid, F., Usman, A., Phetrus Johan, M., & Alfian Zainuddin, A. (2021) · Journal of Rehabilitation Medicine · doi:10.2340/16501977-2835 · Cited by 21
“The uCTX-II level is one of several cartilage degradation biomarkers, wherein increased levels of uCTX-II correlate with radiological severity and cartilage thinning on magnetic resonance imaging (MRI) examination (14, 21, 22).”
Background
Metadata
- Authors
- Attur, M., Krasnokutsky-Samuels, S., Samuels, J., & Abramson, S. B.
- Venue
- Current Opinion in Rheumatology
- Published
- 2013-01
- Volume
- 25
- Issue
- 1
- Pages
- 136-144
- ISSN
- 1040-8711 (ISSN-L)
- OpenAlex
- W2052204542
- Cited by
- 178
- References
- 2
- FWCI
- 8.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prognostic biomarkers in osteoarthritis. https://app.cochat.ai/papers/10.1097/bor.0b013e32835a9381
- The paper
- Attur, M., Krasnokutsky-Samuels, S., Samuels, J., & Abramson, S. B. (2013). Prognostic biomarkers in osteoarthritis. Current Opinion in Rheumatology. https://doi.org/10.1097/bor.0b013e32835a9381
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.